Physician profile
Casey Anthony
NPI 1730669946
$1,383.99
in general payments reported to CMS, 2019-2025
8 companies · $24.08 in 2025
The $24.08 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $384 · 2023: $297 · 2024: $679 · 2025: $24.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $377.06 | 2023-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Sight Sciences, INC. | $342.80 | 2022-2024 | Omni Surgical System |
| Alcon Vision LLC | $274.99 | 2023-2024 | Clareon, Centurion |
| Rxsight INC | $130.18 | 2022 | |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Stryker Corporation | $90.51 | 2024 | Na |
| Astellas Pharma US INC | $24.08 | 2025 | Veozah |
| Bausch & Lomb Americas INC. | $19.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.